0001179110-12-012532.txt : 20120807 0001179110-12-012532.hdr.sgml : 20120807 20120807190220 ACCESSION NUMBER: 0001179110-12-012532 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120803 FILED AS OF DATE: 20120807 DATE AS OF CHANGE: 20120807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Winningham Rick E CENTRAL INDEX KEY: 0001302443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 121014725 MAIL ADDRESS: STREET 1: 901 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0306 4 2012-08-03 0 0001080014 THERAVANCE INC THRX 0001302443 Winningham Rick E THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer Common Stock 2012-08-03 4 M 0 80645 3.10 A 602491 D Common Stock 2012-08-03 4 M 0 64516 3.10 A 667007 D Common Stock 2012-08-03 4 S 0 39549 27.77 D 627458 D Common Stock 2012-08-03 4 S 0 36200 28.15 D 591258 D Stock Option (Right to Buy) 3.10 2012-08-03 4 M 0 80645 0 D 2013-01-24 Common Stock 80645 0 D Stock Option (Right to Buy) 3.10 2012-08-03 4 M 0 64516 0 D 2013-01-24 Common Stock 64516 0 D Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c). This transaction was executed in multiple trades at prices ranging from $27.46 to $27.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $28.01 to $28.47. The price reported above reflects the weighted average sale price. Immediately exercisable. Rick E Winningham 2012-08-07